1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
PetMed Express, Inc.

PetMed Express, Inc.

PETS
PetMed Express, Inc.US flagNASDAQ Global Select
1.80
USD
-0.03
- -
38.46MMarket Cap
PetMed Express, Inc.
PETS
(NASDAQ Global Select)

Recent

price

1.80

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
10.29
11.56
11.43
11.73
11.46
11.66
12.32
13.46
13.85
14.18
15.13
13.5
12.21
13.44
- -
8.56
- -
Revenue per Share
0.93
0.81
0.86
0.9
0.87
1.02
1.18
1.83
1.84
1.29
1.19
0.93
0.25
-0.37
- -
-2.74
- -
Basic EPS, GAAP
1.31
0.96
0.64
0.68
1.56
0.05
1.81
1.8
2.18
1.82
1.88
0.83
1.11
-0.01
- -
-1.58
- -
Free Cash Flow per Basic Share
0.48
0.53
1.6
0.67
0.69
0.73
0.77
0.86
1.07
1.09
1.13
1.21
1.21
0.61
- -
- -
- -
Dividend per Share
4.31
3.94
3.21
3.45
3.62
3.89
4.28
5.23
5.97
6.3
6.69
5.54
4.52
3.51
- -
0.44
- -
Book Value per Share
4.27
3.9
3.17
3.48
3.73
4.09
4.57
5.65
6.54
6.44
7
6.08
5.38
2.89
- -
1.12
- -
Tangible Book Value per Share
23
21
20
20
20
20
20
20
20
20
20
20
20
20
21
21
- -
Basic Weighted Avg Shares
232
238
228
233
229
235
249
274
283
284
304
272
248
274
- -
179
179
Sales/Revenue/Turnover
14.26
10.92
11.85
12.09
12.78
13.8
15.04
19.04
16.29
10.9
10.06
8.92
2.44
-2.98
- -
-17.55
-17.55
Operating Margin (%)
1
1
1
1
1
1
1
2
2
2
2
3
4
7
- -
9
9
Depreciation Expense
21
17
17
18
17
21
24
37
38
26
24
19
5
-7
- -
-57
-57
Net Income, GAAP
37.28
36.83
37.14
36.72
37.21
36.85
37.19
30.69
23.17
23.73
22.72
22.61
30.96
- -
- -
- -
- -
Effective Tax Rate (%)
9.01
6.99
7.53
7.7
7.61
8.76
9.56
13.62
13.32
9.1
7.88
6.87
2.08
-2.72
- -
-32
-32
Profit Margin (%)
81
78
60
66
72
61
63
87
108
105
116
95
73
21
- -
-8
-8
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
LT Debt
97
81
64
70
75
83
93
116
135
130
141
123
110
97
- -
29
29
Total Equity
21.37
18.4
23.2
26.39
25.11
25.62
26.39
34.27
28.24
17.75
17.25
12.96
2.94
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
21.8
18.69
23.65
27.09
24.75
27.3
28.89
38.66
33.03
20.81
18.37
15.22
5.05
-9.14
- -
-1,234.08
-141.69
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
1
1
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
21
21
21
Market Capitalization
75
99
- -

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
71
68
44
Cash, Cash Equivalents & STI
52
50
21
Accounts Receivable, Net
2
2
2
Inventories
13
12
14
Total Current Liabilities
49
48
52
Payables & Accruals
47
46
51
ST Debt
- -
- -
- -
Deferred Revenue
2
1
1

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-70.08%
Free Cash Flow
- -
- -
16,914.95%
Net Income, GAAP
- -
- -
667.5%
Sales/Revenue/Turnover
- -
- -
-34.69%
Total Cash Common Dividend
- -
- -
-99.83%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
78
71
65
67
274
2025
66
58
52
- -
- -
2026
51
44
41
43
179

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
-0.25
-0.37
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
-2.74

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.61
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Crestchem Limited (CRSTCHM.BO)
Zenith Drugs Ltd. (ZENITHDRUG.NS)
LBX Pharmacy Chain Joint Stock Company (603883.SS)
Delota Corp. (SYDRF)
Zenotech Laboratories Limited (ZENOTECH.BO)
Paion AG (0NF3.L)
Business
PetMed Express, Inc. (PETS) operates as a leading online pet pharmacy in the United States, offering prescription and non-prescription medications, health products, food, supplements, and supplies for dogs, cats, and horses through its websites PetMeds.com and PetCareRx.com, mobile app, toll-free number, and direct mail. The company provides a comprehensive range of products including heartworm preventatives, flea and tick control, arthritis and joint care medications, thyroid and diabetes treatments, pain relief, blood pressure drugs, vitamins, nutritional supplements, hygiene items, pet foods, beds, crates, stairs, treats, and generic substitutes; it also maintains veterinary and pet insurance service partnerships. Founded in 1996 and headquartered in Delray Beach, Florida, PetMed Express serves consumers nationwide with over 15,000 stock-keeping units focused on affordable pet healthcare. In May 2025, the company announced a strategic partnership with telemedicine provider Dutch, enabling pet owners in 34 states to access licensed veterinarians via video for prescriptions directly fulfilled by PetMeds' inventory; it recently extended its shareholder rights plan in November 2025 and reported strategic updates to executive leadership.

Company News

MCPAPIChat

  • zacks.com

    PETS Q4 Earnings Call Focuses on Turnaround Foundation

  • zacks.com

    PetMed (PETS) Reports Q4 Loss, Beats Revenue Estimates

  • seekingalpha.com

    PetMed Express, Inc. (PETS) Q4 2026 Earnings Call Prepared Remarks Transcript

  • globenewswire.com

    PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results

  • globenewswire.com

    PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026

  • proactiveinvestors.co.uk

    Broker sees vet business as hidden value driver at Pets at Home

  • proactiveinvestors.co.uk

    Pets at Home rejigs shareholder returns as new CEO backs outlook

  • globenewswire.com

    PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels

  • globenewswire.com

    PetMed Express, Inc. Investigated by the Portnoy Law Firm

  • defenseworld.net

    Head-To-Head Comparison: PetMed Express (NASDAQ:PETS) vs. RideNow Group (NASDAQ:RDNW)

  • defenseworld.net

    PetMed Express (NASDAQ:PETS) Shares Cross Above Two Hundred Day Moving Average – What’s Next?

  • defenseworld.net

    PetMed Express (NASDAQ:PETS) Stock Price Passes Above Two Hundred Day Moving Average – Should You Sell?

  • prnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

  • defenseworld.net

    PetMed Express (NASDAQ:PETS) Shares Cross Above 200 Day Moving Average – What’s Next?

  • globenewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

  • defenseworld.net

    Newegg Commerce (NASDAQ:NEGG) vs. PetMed Express (NASDAQ:PETS) Head to Head Analysis

  • prnewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

  • globenewswire.com

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

  • proactiveinvestors.co.uk

    Pets at Home appoints ex-Waitrose boss as new CEO

  • businesswire.com

    Cardone Ventures Announces Unsolicited $4.25 Per Share All-Cash Proposal to Acquire PetMed Express